Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis

Background. There is raised interest in the involvement of interleukin-(IL-)23/T-helper 17 cells (Th17) axis in the pathogenesis of psoriasis. Objectives. To compare the effect of narrow band ultraviolet B (NB-UVB) and methotrexate (MTX) therapy on serum levels of IL-17 and IL-23 in psoriatic patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Tarek Mahmoud Elghandour, Sahar El Sayed Youssef, Dalia Gamal Aly, Mohamed Said Abd Elhameed, Mehrevan Mostafa Abdel Moneim
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/618269
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564585473769472
author Tarek Mahmoud Elghandour
Sahar El Sayed Youssef
Dalia Gamal Aly
Mohamed Said Abd Elhameed
Mehrevan Mostafa Abdel Moneim
author_facet Tarek Mahmoud Elghandour
Sahar El Sayed Youssef
Dalia Gamal Aly
Mohamed Said Abd Elhameed
Mehrevan Mostafa Abdel Moneim
author_sort Tarek Mahmoud Elghandour
collection DOAJ
description Background. There is raised interest in the involvement of interleukin-(IL-)23/T-helper 17 cells (Th17) axis in the pathogenesis of psoriasis. Objectives. To compare the effect of narrow band ultraviolet B (NB-UVB) and methotrexate (MTX) therapy on serum levels of IL-17 and IL-23 in psoriatic patients. Methods. Thirty patients with severe plaque psoriasis were included: 15 patients received NB-UVB three times weekly (group I) and 15 patients received MTX 0.3 mg/kg per week (group II), both for 8 weeks. Before and after treatment, serum levels of IL-17 and IL-23 were investigated by ELISA technique and psoriasis area and severity index (PASI) was calculated. Results. After treatment, all patients showed a reduction in their PASI score, IL-17 and IL-23 serum levels with a nonsignificant difference between both therapeutic modalities (P value >0.05). A positive correlation was detected between the percent of reduction of IL-17, IL-23 and the percent of reduction of PASI score for patients receiving both treatments. No correlation was found between the percent of reduction of IL-17, IL-23 and duration of disease or age of all patients in this study. Conclusion. Interleukin-17 and IL-23 serum level may serve as a potential biomarker for predicting the prognosis and therapeutic response of NB-UVB or MTX in treating psoriasis.
format Article
id doaj-art-ffb0bbec43d540dabcfb67a0dfbcb8e3
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-ffb0bbec43d540dabcfb67a0dfbcb8e32025-02-03T01:10:42ZengWileyDermatology Research and Practice1687-61051687-61132013-01-01201310.1155/2013/618269618269Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe PsoriasisTarek Mahmoud Elghandour0Sahar El Sayed Youssef1Dalia Gamal Aly2Mohamed Said Abd Elhameed3Mehrevan Mostafa Abdel Moneim4Department of Dermatology, Venereology, and Andrology, Ain Shams University, Abassya Square, Cairo 11566, EgyptDepartment of Dermatology, Venereology, and Andrology, Ain Shams University, Abassya Square, Cairo 11566, EgyptDepartment of Dermatology and Venereology, National Research Center, El-Bhoos Street, Dokki, Giza 12622, EgyptDepartment of Dermatology and Venereology, National Research Center, El-Bhoos Street, Dokki, Giza 12622, EgyptDepartment of Medical Biochemistry, National Research Center, El-Bhoos Street, Dokki, Giza 12622, EgyptBackground. There is raised interest in the involvement of interleukin-(IL-)23/T-helper 17 cells (Th17) axis in the pathogenesis of psoriasis. Objectives. To compare the effect of narrow band ultraviolet B (NB-UVB) and methotrexate (MTX) therapy on serum levels of IL-17 and IL-23 in psoriatic patients. Methods. Thirty patients with severe plaque psoriasis were included: 15 patients received NB-UVB three times weekly (group I) and 15 patients received MTX 0.3 mg/kg per week (group II), both for 8 weeks. Before and after treatment, serum levels of IL-17 and IL-23 were investigated by ELISA technique and psoriasis area and severity index (PASI) was calculated. Results. After treatment, all patients showed a reduction in their PASI score, IL-17 and IL-23 serum levels with a nonsignificant difference between both therapeutic modalities (P value >0.05). A positive correlation was detected between the percent of reduction of IL-17, IL-23 and the percent of reduction of PASI score for patients receiving both treatments. No correlation was found between the percent of reduction of IL-17, IL-23 and duration of disease or age of all patients in this study. Conclusion. Interleukin-17 and IL-23 serum level may serve as a potential biomarker for predicting the prognosis and therapeutic response of NB-UVB or MTX in treating psoriasis.http://dx.doi.org/10.1155/2013/618269
spellingShingle Tarek Mahmoud Elghandour
Sahar El Sayed Youssef
Dalia Gamal Aly
Mohamed Said Abd Elhameed
Mehrevan Mostafa Abdel Moneim
Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
Dermatology Research and Practice
title Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
title_full Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
title_fullStr Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
title_full_unstemmed Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
title_short Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
title_sort effect of narrow band ultraviolet b therapy versus methotrexate on serum levels of interleukin 17 and interleukin 23 in egyptian patients with severe psoriasis
url http://dx.doi.org/10.1155/2013/618269
work_keys_str_mv AT tarekmahmoudelghandour effectofnarrowbandultravioletbtherapyversusmethotrexateonserumlevelsofinterleukin17andinterleukin23inegyptianpatientswithseverepsoriasis
AT saharelsayedyoussef effectofnarrowbandultravioletbtherapyversusmethotrexateonserumlevelsofinterleukin17andinterleukin23inegyptianpatientswithseverepsoriasis
AT daliagamalaly effectofnarrowbandultravioletbtherapyversusmethotrexateonserumlevelsofinterleukin17andinterleukin23inegyptianpatientswithseverepsoriasis
AT mohamedsaidabdelhameed effectofnarrowbandultravioletbtherapyversusmethotrexateonserumlevelsofinterleukin17andinterleukin23inegyptianpatientswithseverepsoriasis
AT mehrevanmostafaabdelmoneim effectofnarrowbandultravioletbtherapyversusmethotrexateonserumlevelsofinterleukin17andinterleukin23inegyptianpatientswithseverepsoriasis